Liothyronine hydrochloride

Fmoc-L-Tyr(2,6-Cl2-Bzl)-OH is an Fmoc protected tyrosine derivative that is potentially useful for proteomics studies and solid phase peptide synthesis techniques. Tyrosine is a very important amino acid - one of the few amino acids which is

Fmoc-L-Tyr(2,6-Cl2-Bzl)-OH is an Fmoc protected tyrosine derivative that is potentially useful for proteomics studies and solid phase peptide synthesis techniques. Tyrosine is a very important amino acid - one of the few amino acids which is

Fmoc-L-Tyr(2,6-Cl2-Bzl)-OH is an Fmoc protected tyrosine derivative that is potentially useful for proteomics studies and solid phase peptide synthesis techniques. Tyrosine is a very important amino acid - one of the few amino acids which is

A pyrrolopyrimidine that selectively blocks the activity of two forms of Lck kinase, Lck (64-509) and Lckcd, with IC₅₀ values of stimulated IL-2 production in mice (ED₅₀s = 4 and 25 mg/kg when administered either i.p.

A pyrrolopyrimidine that selectively blocks the activity of two forms of Lck kinase, Lck (64-509) and Lckcd, with IC₅₀ values of stimulated IL-2 production in mice (ED₅₀s = 4 and 25 mg/kg when administered either i.p.

Org41841 is a partial agonist of both luteinizing hormone/chorionic gonadotropin receptor ( LHCGR ) and thyroid-stimulating hormone receptor ( TSHR ) with EC 50 s of 0.2 and 7.7 μM, respectively.In VitroFunctional assays demonstrate that Org41841 is

Org41841 is a partial agonist of both luteinizing hormone/chorionic gonadotropin receptor ( LHCGR ) and thyroid-stimulating hormone receptor ( TSHR ) with EC 50 s of 0.2 and 7.7 μM, respectively.In VitroFunctional assays demonstrate that Org41841 is

Org41841 is a partial agonist of both luteinizing hormone/chorionic gonadotropin receptor ( LHCGR ) and thyroid-stimulating hormone receptor ( TSHR ) with EC 50 s of 0.2 and 7.7 μM, respectively.In VitroFunctional assays demonstrate that Org41841 is

Org41841 is a partial agonist of both luteinizing hormone/chorionic gonadotropin receptor ( LHCGR ) and thyroid-stimulating hormone receptor ( TSHR ) with EC 50 s of 0.2 and 7.7 μM, respectively.In VitroFunctional assays demonstrate that Org41841 is

InformationPTC-028 PTC-028 is an orally bioavailable compound that decreases BMI-1 levels by posttranslational modification.TargetsBMI-1In vitroPTC-028 is an orally bioavailable compound that decreases BMI-1 levels by posttranslational modification.

InformationPTC-028 PTC-028 is an orally bioavailable compound that decreases BMI-1 levels by posttranslational modification.TargetsBMI-1In vitroPTC-028 is an orally bioavailable compound that decreases BMI-1 levels by posttranslational modification.

InformationPTC-028 PTC-028 is an orally bioavailable compound that decreases BMI-1 levels by posttranslational modification.TargetsBMI-1In vitroPTC-028 is an orally bioavailable compound that decreases BMI-1 levels by posttranslational modification.